Medical News

RSS

NanoLogix to move R&D operations from Cincinnati to its headquarters in Hubbard

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today it will move its research and development operations from Cincinnati to its headquarters in Hubbard, Ohio.

6 Sep 2011

Latest Consumer Reports Index: 16.3% of Americans unable to pay medical bills

When we visit our doctors, we don't typically think of ourselves as "consumers" or buyers of health care, but in these tough times, that is precisely the role a patient needs to play to avoid drowning in a sea of medical bills.

6 Sep 2011

ICS, Quintiles enter agreement with Pacira to support launch of EXPAREL

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has entered into agreements with Quintiles Commercial US, Inc. and Integrated Commercialization Services, Inc. (ICS) to support the anticipated launch of EXPAREL, should it be approved by the Food and Drug Administration (FDA) later this year.

6 Sep 2011

The Arthritis Society warns Canadians to check for OA

Canadians who never have their joint pains and aches examined by a doctor could be making the problem much worse, The Arthritis Society warns.

6 Sep 2011

Pharmasset reports SVR results from PSI-7977 phase 2b combination study on HCV genotype 1

Pharmasset, Inc., announced today sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 400 mg dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 1 who have not been treated previously. 43 out of 44 (98%) evaluable subjects achieved an SVR12, defined as HCV RNA below the limit of detection (<15 IU/mL) 12 weeks after the completion of treatment.

6 Sep 2011

Toshiba introduces Kalare Wireless X-ray system

Designed to improve productivity and efficiency in X-ray imaging, Toshiba America Medical Systems, Inc. has introduced the Kalare Wireless X-ray system. The Kalare Wireless includes the advanced technology from the original Kalare, plus a new wireless 14"x17" panel with a rotating bucky tray designed for optimal detector movement.

6 Sep 2011

Bariatric surgery is cost-effective but has long-term complications

The majority of people who undergo bariatric weight-loss surgery benefit from the procedure, but long-term complications and further surgery are not uncommon, according to a UK paper on late postoperative complications in the October issue of BJS, the British Journal of Surgery.

6 Sep 2011

European Neurotech Investing & Partnering Summit to take place in Helsinki

The inaugural European Neurotech Investing & Partnering Summit takes place in Helsinki this week. It features keynotes on the state of the European neurotech industry, investor analysis, as well as company and research project presentations on next generation treatments emerging in the EU for unmet needs of brain and nervous system disorders like Alzheimer's, addiction, depression, schizophrenia, Parkinson's, Huntington's, stroke and more.

6 Sep 2011

Waters launches new single quadrupole mass detector at 2011 JAIMA Expo

Waters Corporation today introduced the Waters® SQ Detector 2, a new single quadrupole mass detector, at the 2011 JAIMA Expo.

6 Sep 2011

CHEMIE.DE now offers unparalleled access to scientific data

With its new search facility and directories of scientific publications from numerous journals in chemistry, pharma, life science and related disciplines, CHEMIE.DE Information Service GmbH now offers unparalleled access to scientific data, providing convenient filtering options for a unique search experience.

6 Sep 2011

Amakem receives €18m in Series A round of funding

Amakem NV today announced it has raised €18m with a syndicate of leading life sciences investors to advance its ophthalmology drug development portfolio and progress its lead candidate, AMA0076 for glaucoma, to clinical proof of concept.

6 Sep 2011

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

NOXXON Pharma today announced the initiation of a Phase I clinical trial for NOX-H94, the Company's third compound to enter the clinic. NOX-H94 is a Spiegelmer designed to treat anemia of chronic disease by targeting the peptide hormone hepcidin, the key regulator of iron metabolism.

6 Sep 2011

Biologists identify mechanism of H. pylori that damages DNA of gastric mucosal cells

The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world.

6 Sep 2011

Ontario Liberal Party includes OMA recommended health care policy initiatives in election platform

Ontario's doctors were pleased to learn that the Ontario Liberal Party has included several health care policy initiatives in their election platform as recommended by the Ontario Medical Association.

6 Sep 2011

AMA releases new Current Procedural Terminology codes

Friday September 2, 2011 the AMA released new Current Procedural Terminology (CPT) codes that will be reported by hospitals, physicians and ambulatory centers providing coverage for additional treatment options for cancer patients.

6 Sep 2011

Gene variants that help regulate serotonin may serve as predictor of risk for PSTD symptoms

Data in a study published in the Archives of General Psychiatry suggest that certain variants of a gene that helps regulate serotonin, may serve as a useful predictor of risk for symptoms related to posttraumatic stress disorder (PTSD) following a trauma.

6 Sep 2011

McMaster team demonstrates essential role of AMPK enzyme in exercise

You may think your lack of resolve to get off the couch to exercise is because you're lazy, but McMaster University researchers have discovered it may be you are missing key genes.

6 Sep 2011

Sectra reports net sales of SEK 169.3 million for first quarter 2011

IT and medical technology company Sectra's profit after net financial items for the company's first quarter, May - July 2011, rose 25.6% to SEK 16.2 million (12.9), corresponding to a profit margin of 9.6% (7.5). The Group reports an operating profit of SEK 6.5 million (9.0) and net sales of SEK 169.3 million (172.8). Order bookings rose 13.8% to SEK 190.8 million.

6 Sep 2011

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced positive topline data from its Phase II SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin's Lymphoma.

6 Sep 2011

Major difference in twin birth weights linked to increased risk of health complications

The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins.

6 Sep 2011